Suppr超能文献

分子量对聚(β-氨基酯)固有免疫原活性的影响

Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters).

作者信息

Andorko James I, Pineault Kevin G, Jewell Christopher M

机构信息

Fischell Department of Bioengineering, University of Maryland, College Park, Maryland.

Department of Microbiology and Immunology, University of Maryland Medical School, Baltimore, Maryland.

出版信息

J Biomed Mater Res A. 2017 Apr;105(4):1219-1229. doi: 10.1002/jbm.a.35970. Epub 2017 Jan 23.

Abstract

Polymeric carriers are ubiquitously studied in vaccine and drug delivery to control the encapsulation, kinetics, and targeting of cargo. Recent research reveals many polymers can cause immunostimulatory and inflammatory responses, even in the absence of other immune signals. However, the extent to which this intrinsic immunogenicity evolves during degradation is understudied. Here we synthesized a small library of poly(beta amino esters) (PBAEs) that exhibit different starting molecular weights (MWs), but with similar and rapid degradation rates. Primary dendritic cells (DCs) treated with free PBAEs, either intact or degraded to form low MW fragments, were not activated. In contrast particles formed from PBAEs at different extents of degradation caused differential expression of classical DC activation markers (for example, CD40, CD80, CD86, MHCII), as well as antigen presentation. During degradation, activation levels changed with changing physicochemical properties (for example, MW, concentration, size, charge). Of note, irrespective of starting MW, immunogenicity peaked when the MW of degrading PBAEs decreased to a range of ∼1500-3000 Da. These findings could help inform design of future carriers that exploit the dynamic interactions with the immune system as materials degrade, leading to carriers that deliver cargo but also help direct the immune responses to vaccine or immunotherapy cargo. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 1219-1229, 2017.

摘要

聚合物载体在疫苗和药物递送中被广泛研究,以控制药物的包封、动力学和靶向性。最近的研究表明,即使在没有其他免疫信号的情况下,许多聚合物也会引发免疫刺激和炎症反应。然而,这种内在免疫原性在降解过程中的演变程度尚未得到充分研究。在这里,我们合成了一个小型的聚(β-氨基酯)(PBAE)文库,这些PBAE具有不同的起始分子量(MW),但降解速率相似且较快。用完整的或降解形成低分子量片段的游离PBAE处理的初级树突状细胞(DC)未被激活。相比之下,由不同降解程度的PBAE形成的颗粒导致经典DC激活标志物(例如CD40、CD80、CD86、MHCII)的差异表达以及抗原呈递。在降解过程中,激活水平随着物理化学性质(例如MW、浓度、大小、电荷)的变化而改变。值得注意的是,无论起始MW如何,当降解的PBAE的MW降至约1500-3000 Da范围内时,免疫原性达到峰值。这些发现有助于为未来载体的设计提供信息,这些载体利用材料降解时与免疫系统的动态相互作用,从而产生既能递送药物又能帮助引导针对疫苗或免疫治疗药物的免疫反应的载体。©2017威利期刊公司。《生物医学材料研究杂志》A部分:105A:1219-1229,2017年。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验